Ignite Creation Date:
2024-05-06 @ 2:57 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04486651
Status:
UNKNOWN
Last Update Posted:
2021-01-28
First Post:
2020-07-22
Brief Title:
HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
Sponsor:
Organization:
Taizhou Hanzhong biomedical co LTD